Juan Tang Selected Research

arabinosyl- N(6)- hydroxyadenine- 9- beta- D- arabinofuranosyl- 6- hydroxylaminopurine

12/2019

Synergistic effect and reduced toxicity by intratumoral injection of cytarabine-loaded hyaluronic acid hydrogel conjugates combined with radiotherapy on lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Tang Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 02/2009
16	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 03/2007
12	Neoplasm Metastasis (Metastasis) 07/2022 - 03/2007
8	Inflammation (Inflammations) 10/2019 - 08/2014
6	Lung Neoplasms (Lung Cancer) 12/2021 - 01/2013
6	Hypoxia (Hypoxemia) 01/2021 - 01/2013
6	Fibrosis (Cirrhosis) 01/2019 - 01/2015
4	Carcinoma (Carcinomatosis) 09/2021 - 01/2013
4	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 12/2012
4	Breast Neoplasms (Breast Cancer) 09/2021 - 11/2014
4	Myocardial Infarction 01/2021 - 01/2017
4	Infections 10/2019 - 03/2014
3	Multiple Myeloma 12/2019 - 06/2014
3	Carcinogenesis 01/2019 - 01/2015
3	Ureteral Obstruction 01/2019 - 01/2015
3	Hypercholesterolemia 01/2018 - 01/2010
3	Osteosarcoma (Osteogenic Sarcoma) 01/2014 - 05/2009
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 07/2022 - 11/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 10/2019
2	Melanoma (Melanoma, Malignant) 01/2022 - 05/2021
2	Gastroesophageal Reflux (GERD) 06/2021 - 10/2017
2	Dyslipidemias (Dyslipidemia) 03/2021 - 01/2017
2	COVID-19 01/2021 - 01/2020
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 05/2020
2	Thalassemia 01/2021 - 11/2015
2	Thrombosis (Thrombus) 03/2020 - 12/2017
2	Liver Neoplasms (Liver Cancer) 03/2020 - 06/2017
2	Obesity 01/2020 - 04/2017
2	Adenocarcinoma of Lung 04/2019 - 01/2017
2	Infarction (Infarctions) 01/2018 - 01/2018
2	Atherosclerosis 12/2017 - 01/2017
2	Weight Loss (Weight Reduction) 04/2017 - 01/2015
1	Cardiomegaly (Heart Hypertrophy) 02/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Wounds and Injuries (Trauma) 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2021
1	Mesothelioma 09/2021
1	Stomach Neoplasms (Stomach Cancer) 09/2021

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2007
8	Matrix Metalloproteinases (MMPs)IBA 03/2015 - 03/2007
6	Pharmaceutical PreparationsIBA 01/2022 - 07/2013
5	Small Interfering RNA (siRNA)IBA 07/2018 - 12/2009
5	IntegrinsIBA 01/2014 - 01/2009
4	CytokinesIBA 01/2021 - 06/2015
3	AntigensIBA 01/2022 - 03/2007
3	VimentinIBA 01/2021 - 09/2009
3	Cadherins (E-Cadherin)IBA 01/2021 - 01/2019
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2015
3	LigandsIBA 11/2020 - 01/2019
3	RNA (Ribonucleic Acid)IBA 03/2020 - 07/2015
3	InflammasomesIBA 01/2020 - 07/2015
3	5- methyl- 1- (3- fluorophenyl)- 2- (1H)- pyridoneIBA 06/2018 - 09/2015
3	AntibodiesIBA 06/2017 - 03/2007
3	ProstaglandinsIBA 01/2017 - 07/2013
2	Prostaglandins GIBA 07/2022 - 03/2019
2	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2021
2	HydrogelsIBA 12/2021 - 12/2019
2	Messenger RNA (mRNA)IBA 09/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 09/2021 - 10/2017
2	SolventsIBA 03/2021 - 11/2020
2	CollagenIBA 01/2021 - 01/2019
2	SolutionsIBA 01/2021 - 01/2020
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 05/2020
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2020 - 10/2011
2	Immunoglobulin G (IgG)IBA 01/2020 - 09/2006
2	Recombinases (Recombinase)IBA 01/2020 - 01/2018
2	PIK-C98IBA 12/2019 - 01/2015
2	ChemokinesIBA 10/2019 - 01/2019
2	Insulin-Like PeptidesIBA 04/2019 - 12/2018
2	salicylhydroxamic acid (SHAM)IBA 01/2019 - 01/2015
2	OvalbuminIBA 01/2018 - 11/2014
2	LipidsIBA 01/2018 - 01/2017
2	LDL Receptors (LDL Receptor)IBA 01/2017 - 01/2010
2	Immunoglobulins (Immunoglobulin)IBA 03/2015 - 02/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 01/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2014 - 07/2013
2	Biological ProductsIBA 01/2013 - 12/2012
2	Polysaccharides (Glycans)IBA 01/2013 - 01/2010
2	Annexin A2 (Annexin II)IBA 12/2011 - 02/2010
1	CateninsIBA 07/2022
1	pentagalloylglucoseIBA 07/2022
1	Triglycerides (Triacylglycerol)IBA 02/2022
1	EpitopesIBA 01/2022
1	6-methyladenineIBA 01/2022
1	Bispecific AntibodiesIBA 01/2022
1	EndostatinsIBA 12/2021
1	Oxygen (Dioxygen)IBA 12/2021
1	Thymidine Monophosphate (TMP)IBA 12/2021
1	Shenqi JiangtangIBA 11/2021
1	Xanthine DehydrogenaseIBA 09/2021
1	Nucleic AcidsIBA 05/2021

Therapy/Procedure

13	Therapeutics 01/2022 - 03/2014
6	Immunotherapy 01/2022 - 01/2019
3	Radiotherapy 12/2021 - 12/2019
2	Transplantation 12/2021 - 07/2019
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
2	Hepatectomy 09/2018 - 11/2015
2	Oral Administration 01/2015 - 06/2014
1	Injections 12/2021